| Subject |
Ovaries -- Cancer -- Treatment.
|
|
Ovarian Neoplasms -- drug therapy.
|
|
Infusions, Parenteral.
|
|
Quality of Life.
|
| Alt Name |
Alberts, David S. (David Samuel), 1939-
|
|
Clouser, Mary C.
|
|
Hess, Lisa M.
|
| Description |
1 online resource (viii, 153 pages) : illustrations (some color) |
|
polychrome rdacc |
| Bibliography Note |
Includes bibliographical references and index. |
| Contents |
Current chemotherapy of ovarian cancer -- Principles of intraperitoneal chemotherapy -- Intraperitoneal chemotherapy: phase III trials -- Criteria for using intraperitoneal (IP) chemotherapy for advanced ovarian cancer -- Selection and placement of intraperitoneal catheters for IP chemotherapy for ovarian cancer -- Selection of drugs for intraperitoneal chemotherapy for ovarian cancer -- Administration guidelines for intraperitoneal chemotherapy for ovarian cancer -- Novel drugs for intraperitoneal therapy for ovarian cancer -- Cytoreductive surgery and perioperative intraperitoneal chemotherapy: an ongoing research effort -- Health-related quality of life and patient-reported outcomes. |
| Summary |
Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Chemotherapy have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guideli. |
| Note |
Print version record. |
| ISBN |
9783642121302 |
|
3642121306 |
|
9783642121296 |
|
3642121292 |
| OCLC # |
668079990 |
|
Search 
Search 
Previous Item
Permanent Link
